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Background: Leonurus heterophyllus sweet has been suggested to have cardioprotective effects against heart
diseases, including ischemic diseases and ventricular remodeling. However, the active ingredients of the herb and
the underlying mechanisms are poorly understood. The aim of the present study was to investigate the effects of
stachydrine (STA), a major constituent of Leonurus heterophyllus sweet, on norepinephrine (NE) induced hypertrophy
and the changes of calcium transients in neonatal rat cardiomyocytes.
Methods: Ventricular myocytes from 1-day-old Wistar rats were isolated and cultured in DMEM/F12 with 1 μmol/L
norepinephrine in the presence or absence of 10 μmol/L STA for 72 h. Cardiomyocytes hypertrophy was evaluated
by cell surface area, total protein/DNA content, β/α-MHC mRNA ratio. While calcium handling function was evaluated
by Ca2+-transient amplitude and decay, SERCA2a activity and expression, PLN expression and phosphorylation.
β1-adrenergic receptor system activation was evaluated by the content of cAMP and the activation of PKA.
Results: NE treatment increases the cell surface area, protein synthesis, the expression level of β-MHC and β/α-MHC
ratio. These effects were attenuated by STA. NE-induced hypertrophy was associated with increased Ca2+-transient
amplitude, accelerated decay of the Ca2+-transient, increased phospholamban expression, hyper-phosphorylation at
both the serine-16 and threonine-17 residues, increased intracellular cAMP level, and PKA overactivation. All of which
were significantly inhibited by STA.
Conclusion: These data suggest that STA attenuates norepinephrine-induced cardiomyocyte hypertrophy and has
potential protective effects against β-adrenergic receptor induced Ca2+ mishandling.
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Cardiac hypertrophy, which is characterized by increased
cell size, protein synthesis and reactivation of the fetal
gene program, is an adaptive physiological process in re-
sponse to various extracellular stimuli [1].
Elevated activities of the adrenergic nervous system
(ANS) play central roles in heart failure. The ANS neuro-
transmitter norepinephrine (NE) mediates effects in cardiac
myocytes by binding to adrenergic receptors. β1-AR is the
predominant subtype in the myocardium, representing 75%
to 80% of total β-AR. β1-AR induces the formation of* Correspondence: lurong@shutcm.edu.cn
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unless otherwise stated.cAMP and subsequent activation of PKA. PKA in turn
phosphorylates several downstream targets which are the
key players in cellular calcium handling. Those targets in-
clude: L-type Ca2+ channel, Ryanodine receptor (RyR)
and phospholamban (PLN) [2,3]. However, β-AR singal-
ing pathoways undergo a number of adaptive and mal-
adaptive regulatory changes as a consequence of heart
failure. Chronic increasing of circulating catecholamine
causes desensitization and downregulation of cardiac β-
AR. Moreover, the β-AR blocker therapy improves sur-
vival in patients with chronic heart failure which is
strongly suggestive that β-AR hyper-reactivation is in-
volved in heart failure progression [4].
Leonurus heterophyllus Sweet, commonly called mother-
wort, belongs to the Labiatae family, is a traditional ChineseThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Chemical structure of stachydrine.
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“mother-benefiting herb” if translated literally, has been
used traditionally in gynecology and obstetrics. During the
last few decades, experimental studies and clinical trials
have demonstrated that the herb has pharmacological ef-
fects on ischemic diseases by increasing coronary blood
flow, improving heart function, and inhibiting blood plate-
let aggregation [5]. Recently, our group determined that
aqueous extracts and alkaloids extracted from Leonurus
Heterophyllus Sweet have beneficial effects on left ven-
tricular dysfunction or remodeling in rats [6,7]. However,
the active ingredient of the herb and the underlying mech-
anisms are unknown.
In the present study, we examined the effects of the crys-
talline alkaloid STA, which is one of the major constituents
of Leonurus heterophyllus Sweet, on norepinephrine-
induced neonatal rat cardiomyocyte hypertrophy and SR
Ca2+ handling.
Methods
This study was approved by the Institutional Animal
Care and Use Committee of Shanghai University of
Traditional Chinese Medicine.
Neonatal cardiac myocyte culture and treatment protocol
Cardiac myocytes were obtained from the ventricles of
1-day-old Wistar rats and prepared using a modified
method as described previously [8]. The cardiac myo-
cytes were plated in DMEM/F-12 (1:1) with 10% horse
serum and 5% fetal calf serum. After 48 hours, the car-
diac myocytes were incubated in serum-free DMEM/F12
supplemented with 1 ug/mL insulin, 5 μg/mL transferrin
and 0.1 mmol/L BrdU. The cardiac myocytes were then
treated with norepinephrine (NE, 1 μmol/L) for 72 hours
in the presence or absence of carvedilol (CAR, as a posi-
tive control, 1 μmol/L) or STA (10 μmol/L), whereas the
controls were cultured in medium without treatment.
Chemicals and reagents
Chemically pure STA was obtained from the chemistry
laboratory at the Institute of Chinese Materia Medica,
Shanghai University of Traditional Chinese Medicine. It
was identified on the basis of chemical and spectro-
scopic evidence using the general formula C7H13NO2.
The structure of STA is illustrated in Figure 1 [9]. Car-
vedilol was purchased from the Boehringer Mannheim
Company. All chemicals were of analytical grade or the
best grade commercially available.
Cell surface area analysis
The cardiac myocytes were washed in Ca2+- and Mg2+-free
PBS and fixed in 3.7% paraformaldehyde-PBS (Fisher,
Fairlawn, NJ, USA) for 10 minutes at room temperature,
then washed in 0.1% Triton X-100 for 5 min. The cells weredouble-labeled with DAPI (for DNA nuclear labeling) and
phalloidin (for F-actin labeling) conjugated with Alexa
Fluor 488 (Invitrogen, Carlsbad, CA, USA). Fluorescently
labeled cells were then viewed using a fluorescent micro-
scope (Axiovert 40 CFL, Carl Zeiss, Germany). The cells
within each field were outlined, and the two-dimensional
area was obtained using I-solution software (IMT i-
Solution Inc., Daejeon, Korea). The final mean surface area
of each group was determined using 150 cells from 3 inde-
pendent experiments.Total protein/DNA content ratio analysis
The cells were collected using trypsin/EDTA, and then
split into two equal aliquots for protein and DNA mea-
surements. One aliquot was resuspended in protein lysis
buffer (50 mmol/L Tris–HCl, pH 7.4, 2 mmol/L EDTA,
1% Nonidet P-40, 100 mmol/L NaCl, 100 mmol/L so-
dium orthovanadate, and 0.1 mmol/L PMSF with
Complete protease cocktail (Roche, Meylan, France)). The
protein concentration was determined using a BCA protein
assay (Pierce, Rockford, IL, USA). The other aliquot was re-
suspended in TEN (10 mmol/L Tris–HCl, pH 7.4, 1 mmol/
L EDTA pH 8.0, and 150 mmol/L NaCl). The DNA con-
centration was determined using Hoechst 33258 (Sigma-
Aldrich, St. Louis, MO, USA) with calf thymus DNA as a
standard (Sigma-Aldrich, St. Louis, MO, USA), as previ-
ously described [10]. The DNA was analyzed at 365 nm ex-
citation and 460 nm emission using a fluorescence
spectrometer (F-4500, Hitachi, Tokyo, Japan). For each well,
the result of protein determination was divided by the
DNA measurement to provide a protein/DNA ratio.
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Cells grown on 30 mm Petri dishes were harvested by scrap-
ing. The total RNA was isolated using Trizol (Invitrogen,
Carlsbad, CA, USA), according to the manufacturer's in-
structions, and the concentration was determined using a
BioPhotometer (Eppendorf, Hamburg, Germany). Comple-
mentary DNA was synthesized from 2.5 μg of total RNA
using a PrimeScript RT reagent Kit (TaKaRa, Dalian, China).
Real time PCR was performed in triplicate and detected by
SYBR Premix Ex Taq™ Kit (TaKaRa, Dalian, China) using
the LightCycler2.0 System (Roche, Basel, Switzerland). The
relative mRNA expression levels were normalized to 18 s
ribosomal RNA. The primers were designed by the web
based program, Oligo Perfect™ Designer (Invitrogen). The
primers used were as follows: 18 s rRNA forward, 5'-A
CGGACCAGAGCGAAAGCAT-3'; 18 s rRNA reverse,
5'-TGTCAATCCT-GTCCGTGTCC-3'; α-MHC forward,
5'-GACACCAGCGCCCACCTG-3'; α-MHC reverse, 5'-A
TAGCAACAGCGAGGCTCTTTCTG-3'; β-MHC for-
ward, 5'-GGAGCTCACCTACCAGACAGA-3'; and β-M
HC reverse, 5'-CTCAGGGCTTC-ACAGGCATCC-3'.
Ca2+-Transient analysis
Free cytosolic calcium was measured in neonatal rat cardi-
omyocytes as previously described [11]. Cardiomyocytes
were plated onto glass coverslips and cultured for 72 hours.
Myocytes were loaded with fura-2/AM (Molecular
Probes, Eugen, OR, USA) by incubating the coverslips
for 30 minutes in 2 mL of Tyrode’s solution containing
(mmol/L) NaCl 137, KCl 5, glucose 15, MgSO4 1.3,
NaH2PO4 1.2, HEPES 20, and CaCl2 1, as well as fura-2/
AM (3 mmol/L) and D-Pluronic (Molecular Probes,
Eugen, OR, USA) (3 mL of 25% [wt/wt] in dimethyl sulfox-
ide). Myocytes were then rinsed with Tyrode’s solution and
maintained for 30 minutes at room temperature to allow
for deesterification of the dye. Coverslips were trans-
ferred to a temperature-regulated chamber (RC-21BRFS,
Warner, Hamden, CT, USA) mounted on a Carl Zeiss
Axio Observer. A1 microscope, Lambda DG-4 mono-
chromator and filter sets(Sutter, Novato, CA, USA), and
cells were perfused with prewarmed modified Tyrode’s so-
lution. Cells were paced by electrical field stimulation
(SIU-102, Warner, Hamden, CT, USA) at 1 Hz, 18 V, 4-
millisecond pulse duration using platinum electrodes.
Fluorescence of intracellular fura-2 was determined by al-
ternatively illuminating cells with 340- and 380-nm light
and measuring emission at 520 nm using an EMCCD
(iXon Ultra 897, Andor, Belfast, BT, UK). The sampling
rate for collection of ratio values was 100 Hz. Images were
recorded and analyzed using the MetaFlour software (Mo-
lecular Devices, Sunnyvale, CA, USA). As previously re-
ported, improper calibration of fura-2 is difficult to exclude
because of compartmentalization in loaded cells and differ-
ences in spectral properties between cells and buffersolutions [12]. So the fura-2 fluorescence ratio was used as
an indicator of free cellular calcium. Diastolic fluorescence
ratio, peak systolic fluorescence ratio, and transient decay
(τ, ms) were used for analysis of transient amplitude.Measurement of SR Ca2+-ATPase activity
The SR membranes from cardiac myocytes were pre-
pared using a modified procedure, as previously de-
scribed [13]. The cardiac myocytes were homogenized
in a buffer containing 300 mmol/L sucrose, 1 mmol/L
PMSF, and 20 mmol/L PIPES. The homogenates were
centrifuged at 500 g for 20 min and at 25000 g for 60 min
to pellet the SR membranes. The SR Ca2+-ATPase activity
was measured using a modified method, as previously de-
scribed [14]. Homogenate protein was added to the solu-
tion containing 200 mmol/L KCl, 20 mmol/L HEPES,
10 mmol/L MgCl2, 3 mmol/L PEP, 0.6 mmol/L NADH,
1 mmol/L EGTA, 7.5 U/ml PK, and 5 U/ml LDH (pH 7.0),
2 μM of the Ca2+ ionophore A-23187 (Sigma-Aldrich, St.
Louis, MO, USA). NADH was measured using a photom-
eter (DU-640, Beckman Instruments, Inc., Fullerton, CA,
USA) with a wavelength of 340 nm at 37°C, and the reac-
tion was started with 1 mmol/L Na2ATP. Absorbance
changes were monitored for 3 min. The Ca2+ ionophore
was added to prevent intraluminal Ca2+ accumulation in
SR, which is inhibitory to Ca2+-ATPase activity [15]. All ex-
periments were performed in triplicate. SERCA2 activity
was calculated in nanomoles of ATP per milligram of pro-
tein per minute from the change of absorption at 340 nm
divided by the extinction coefficient of NADH, in milligrams
of protein per minute. Basal activity was measured in
Ca2+-free buffer in the presence of EGTA (4 mmol/L),
followed by increasing Ca2+ concentrations.Western blotting
The cells were rinsed with cold PBS and then scraped in
ice-cold lysis buffer with protease and phosphatase In-
hibitor Cocktail (Roche, Meylan, France). The protein
concentration was assessed using a BCA Protein assay
(Pierce, Rockford, IL, USA). Then, an equal amount of
protein was separated using a 4-20% SDS-PAGE and
transferred to PVDF membranes (Hybond, Amersham,
Arlington Heights, IL, USA). The blots were incubated
with the appropriate antibodies, including anti-SERCA2a,
anti–phospho-PLN (serine-16, threonine-17) and anti-
PLN (Santa Cruz Blotechnology, CA, USA). The signals
were detected using Super Signal Immobilon Western
Chemiluminescent HRP Substrate (Millipore, France) and
quantified by densitometry using the Image analysis sys-
tem (Bio-Tanon, Shanghai, China). The data were normal-
ized using β-actin to ensure equal loading and were
expressed as a ratio of the experimental group to the con-
trol group.
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The concentration of cellular cAMP was carried out
using the cAMP-Glo assay kit (Promega, Madison, WI,
USA). Briefly, cells were cultured in poly-D-lysine-
coated, white, clear-bottom 96-well plates (Greiner,
Stonehouse, UK) in a density of 104 cells/well. Cells
were lysed to release cAMP, and then the cAMP Detec-
tion Solution, which contains protein kinase A (PKA)
and kinase substrate (Leu-Arg-Arg-Ala-Ser-Leu-Gly), is
added. The Kinase-Glo Reagent is next added to termin-
ate the PKA reaction and detect the remaining ATP via
a luciferase reaction. Plates are read using a microplate-
reading luminometer (Synergy 2, BioTek, Winooski, VT,
US). Relative luminescence output is inversely propor-
tional to cAMP levels.
PKA assay
Protein kinase A (PKA) activity was performed using the
ProFluor PKA assay kit (Promega, Madison, WI, USA).
Briefly, cell lysates were added to the reaction buffer
containing a bisamide rhodamine 110 peptide substrate
and were incubated for 30 min at 25°C. The reaction
was stopped by adding the termination buffer, which
contained a protease that removes amino acids specific-
ally from the non-phosphorylated substrate and results in
the production of highly fluorescent rhodamine 110. Thus,Figure 2 Effects of STA on cell surface area and protein/DNA ratio ch
cardiomyocytes; F-actin is visualized with Alexa Fluor 488-conjugated phall
(blue), ×400. (B) Quantification of cell surface area, n = 150. (C) Ratio of Pro
mean ± SEM. *P < 0.05 versus control, #P < 0.05 versus NE. NE: norepinephrithe fluorescence intensity is inversely correlated with kinase
activity. PKA activity was determined from the fluorescence
intensity of the nonphosphorylated substrate using a Syn-
ergy 2 microplate-reader (BioTek, Winooski, VT, US).
Statistics
Data are presented as the mean ± standard error of mean
(SEM). The intergroup variation between various groups
was measured by one-way analysis of variance (ANOVA)
with Bonferroni’s post hoc test. Results were considered
statistically significant when P values blow 0.05. Data
were analyzed using Statistical Package for Social Sci-
ence (SPSS, Chicago, IL, USA) software version 14.0 for
Microsoft Windows.
Results
Effect of STA on NE-induced changes in cell surface area
and protein synthesis
The myocytes treated with NE for 72 hours demonstrated a
significant increase in the cell surface area, from 744.74 ±
35.30 μm2 to 1606.29 ± 107.91 μm2 (Figure 2A and B, P <
0.05), whereas in the presence of CAR or STA, the cell sur-
face area in the presence of NE was reduced to 720.35 ±
40.31 μm2 and 766.68 ± 14.32 μm2, respectively (Figure 2A
and B, P < 0.05 vs. NE group). STA alone had no effects on
the cell surface area (Figure 2A and B).anges induced by NE. (A) Representative fluorescent micrographs of
oidin stain (green), whereas the nucleus is visualized by DAPI staining
tein/DNA, n = 5. (D) Cell viability, n = 4. The data are expressed as the
ne, CAR: carvedilol, STA: stachydrine.
Figure 3 Effects of STA on NE-induced changes in α- and β-
MHC mRNA expression. qRT-PCR analysis demonstrated (A) α-MHC
and (B) β-MHC gene expression as well as (C) β/α-MHC mRNA ratio
in the presence of NE with CAR or STA for 72 hours (normalized to
18 s ribosomal RNA). The data are expressed as the mean ± SEM,
n = 5. *P < 0.05 versus control, #P < 0.05 versus NE. NE: norepinephrine,
CAR: carvedilol, STA: stachydrine. MHC: myosin heavy chain.
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tein/DNA. As shown in Figure 2C, NE induced a 1.51 ±
0.28-fold increase in the protein/DNA ratio compared
with the controls. The increase for protein/DNA ratio in
the presence of CAR and STA reduced to 1.24 ± 0.16-
fold and 1.38 ± 0.22-fold, respectively (P < 0.05 vs. NE
group). STA alone had no effects on the protein/DNA
ratio (Figures 2C).
Considering that cell viability may interfere with the
protein/DNA ratio, cell viability assays were performed
using Cell Counting Kit-8 (CCK-8, Dojindo Molecular
Technologies, Kumamoto, Japan), which demonstrated
that the cardiac myocyte viability did not significantly
change in the presence of NE with or without STA or
CAR (Figure 2D).
Together, these results indicate that CAR and STA in-
hibit the increase in cell surface area and protein synthe-
sis induced by NE.
Effect of STA on NE-induced changes in the gene
expression of β-MHC and α-MHC
Figure 3A illustrates that expression of the α-MHC gene
did not change significantly in the presence of NE with or
without CAR or STA. However, as shown in Figure 3B, NE
induced a 1.60 ± 0.14-fold upregulation of β-MHC gene ex-
pression after a 72 hour treatment. The upregulation of the
β-MHC gene was abrogated by STA and reduced signifi-
cantly by CAR. Thereby, the β/α-MHC ratio was increased
by NE treatment by 1.70 ± 0.06-fold (Figure 3C) whereas
this was completely prevented by STA. While CAR signifi-
cantly reduced the ratio to 1.297 ± 0.17-fold (Figure 3C,
P < 0.05 vs. NE group). STA alone had no effects on the
MHC isoforms gene expression (Figures 3A,B, and C).
Effect of STA on NE-induced changes in Ca2+ transients
Figure 4A shows representative calcium transient trac-
ings of a group of normal, NE-treated, CAR-treated, and
STA-treated neonatal myocytes. Figure 4B shows that
baseline diastolic fura-2 ratio was similar in the four
groups. Figure 4C shows that NE significantly enhanced
the peak systolic ratio by 36% (P < 0.05). The increases
for peak systolic ratio in the presence of CAR and STA
reduced to 12% and 18%, respectively (P < 0.05 vs. NE
group). Figure 4D shows that the Ca2+-transient decay-
constant reduced by 28% after NE administration, and
Figure 4 Effects of STA on Ca2+ transients changes induced by NE. (A) Representative calcium transient tracings from cardiac myocytes in
NE-treated (NE), NE plus CAR-treated (NE + Car), and NE plus STA-treated (NE + Sta) cells. (B) Baseline of diastolic fura-2 ratio. (C) Peak systolic
fura-2 ratio. (D) Ca2+-transient decay-constant. These data are expressed as the mean ± SEM. n = 20. *P < 0.05 versus control, #P < 0.05 versus NE.
NE: norepinephrine, CAR: carvedilol, STA: stachydrine, SERCA2a: cardiac sarco(endo)plasmic reticulum calcium ATPase.
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0.05 vs. NE group).Effect of STA on NE-induced changes in SERCA2a activity
and protein expression, PLN expression and
phosphorylation
Figure 5A and C show that in the presence of NE with
or without CAR or STA did not change the activity or
expression of SERCA2a significantly.
As shown in Figure 5D, compared with control, PLN
protein levels were markedly increased to 1.73 ± 0.10-
fold by NE administration for 72 hours (P < 0.05). The
NE-induced overexpression of PLN protein was signifi-
cantly decreased by CAR and STA to 0.68 ± 0.03-fold
and 0.37 ± 0.07-fold, respectively (P < 0.05 vs. NE group).
Figure 5E shows that NE dramatically increased PLN
phorsphorylation level at serine-16 to 7.161 ± 2.064 fold
compared with control (P < 0.05); where this was almost
completely prevented by STA (P < 0.05 vs. NE group).
While, the abundance of phorsphorylated PLN at serine-
16 was also decreased by CAR, although still signifi-
cantly greater than control.Similarly, NE significantly increased PLN phorsphoryla-
tion level at threonine-17 by 11.56 ± 2.67 fold (Figure 5F,
P < 0.05) compared with control. CAR and STA decreased
the abundance of phorsphorylated PLN at threonine-17 to
2.26 ± 0.68-fold and 5.43 ± 0.80-fold, respectively (P < 0.05
vs. NE group).Effect of STA on NE-induced changes in cAMP content
and PKA activation
Our observation that NE-induced over phosphorylation
at serine-16 of PLN almost completely prevented by
STA suggests that cAMP/PKA signaling pathway may be
involved in the pharmacological profile. To this end, we
examined intracellular cAMP content and PKA activation.
For the measurement of intracellular cAMP content, the
luminescence intensity is inversely correlated with cAMP
level. As shown in Figure 6A, the luminescence intensity
was markedly decreased by NE administration to 0.5 ±
0.08-fold of control. The decreased of luminescence inten-
sity was abrogated by STA. The decline of luminescence
intensity was increased in the presence of CRA, although
still significantly lower than control.
Figure 5 Effects of STA on SERCA2a and PLN changes induced by NE. (A) Activity of SERCA2a, (B) Representative Western blot, (C) quantification
of SERCA2a, (D) PLN, (E) Ser16 phosphorylation, and (F) Thr17 phosphorylation. These data were normalized to β-actin. The data are expressed as the
mean ± SEM. n = 5. *P < 0.05 versus control, #P < 0.05 versus NE. NE: norepinephrine, CAR: carvedilol, STA: stachydrine, PLN: phospholamban.
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Figure 6 Effect of STA on cAMP content and PKA activation
changes induced by NE. Quantification of intracellular (A) cAMP
content and (B) PKA activation. The luminescence intensity and
fluorescence intensity are inversely correlated with cAMP content
and PKA activation. The data are expressed as the mean ± SEM.
n = 4. *P < 0.05 versus control, #P < 0.05 versus NE. NE: norepinephrine,
CAR: carvedilol, STA: stachydrine, PLN: phospholamban.
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PKA assay is inversely correlated with PKA activation.
As shown in Figure 6B, the fluorescence intensity was
markedly decreased by NE administration to 0.85 ± 0.01
fold of control. The decreased of fluorescence intensity
was completely prevented either by CAR or by STA.
Discussion
The present study determines the potential anti-
hypertrophic effects of STA on neonatal rat cardiomyocytes
exposed to norepinephrine(NE). Our data demonstrate that
STAmarkedly improve Ca2+ handling by reduce Ca2+-transient
amplitude and prolong Ca2+-transient decay constant.Moreover, this study indicates that STA inhibits β1-
adrenergic receptors activation, including reduced cAMP
content and PKA activation.
Cardiomyocytes response to hypertrophic stimuli by
increasing cell size and enhancing protein synthesis [16].
In this study, we demonstrated cell size and protein syn-
thesis dramatically increased by NE treatment, while
STA attenuated these changes.
Another feature of cardiomyocyte hypertrophy is re-
activation of the fetal cardiac gene program, which in-
cludes isoform changes in myosin heavy chain (MHC)
[1]. Decrease in fast-shortening-velocity isoform (α-
MHC) coupled with increases low-shortening-velocity
isoform (β-MHC) may contribute to decreased contract-
ile function [17]. We found that β-MHC mRNA expres-
sion increased whereas α-MHC mRNA did not changed
significantly in NE induced cardiac hypertrophy. This
observation is consistent with other publications [18].
We found STA significantly inhibited the transcription
of β-MHC and decreased the β/α-MHC mRNA ratio.
Together with data on cell size and protein synthesis, we
demonstrated that STA attenuated cardiomyocyte hyper-
trophy induced by NE.
During cardiac hypertrophy and/or heart failure pro-
cesses, there is sustained heightened activation of the
sympathetic nervous system [19]. Stimulation of β1-
adrenergic receptors (β1-AR) by norepinephrine on car-
diac myocytes leads to activation of adenylyl cyclases
and generation of the cAMP [20]. The primary target
for cAMP is protein kinase A (PKA). PKA phosphory-
lates several proteins that are essential for cardiac func-
tion, such as: L-type calcium channels, phospholamban,
ryanodine receptors [21]. The most critical functional
substrate of the cardiac β-adrenergic pathway is phos-
pholamban (PLN). When PLN is phosphorylated, it re-
leased from SERCA2a thus increasing Ca2+ pump
activity [22].
Acute activation of β1-AR enhances cardiac systolic and
diastolic function. However, chronic exposure of the heart
to elevated levels of catecholamines may lead to a progres-
sive deterioration in cardiac structure and function. Widely
established benefits of β-AR antagonist drugs in treating
heart failure strongly support that altered β-AR signaling is
maladaptive and promotes heart failure progression [23].
Our data demonstrated that STA attenuated the enhance-
ment of cAMP level and PKA activation induced by NE
treatment. Together with the ability to prevent phospho-
lamban phosphorylation at Ser16 indicate that STA may
exert antagonistic action at beta-adrenoceptors.
As with all in vitro models, the current results should
be interpreted within the constraints of limitations and
may not be directly comparable with those obtained
in vivo. One of other limitations is the differences in
intracellular calcium handling among neonatal and adult
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involved in the decline of intracellular Ca2+ concentra-
tion are the SERCA2a and the sarcolemmal Na+/Ca2+
exchanger. Several studies have indicated that the func-
tion of SERCA2a in neonatal cardiomyocyte is relatively
less important than that in adults [24]. Considering of
this, further investigations are needed to clarify the ef-
fects of STA on intracellular calcium handling in adult
cardiomyocytes.
Conclusion
This study demonstrated an anti-hypertrophic effect of
STA in cultured neonatal rat cardiomyoctes exposed to
NE. Our data also indicated that STA has potential car-
dioprotective effects against β-adrenergic receptor in-
duced Ca2+ mishandling.
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